These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8493589)

  • 21. [Anti-double strand DNA antibodies and antinuclear antibodies in SLE. I. A new method for determination of anti-double strand DNA antibodies: Trypanosoma equiperdum immunofluorescent method (author's transl)].
    Xu SZ; Wang HZ; Li HJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Mar; 3(1):6-9. PubMed ID: 6458398
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of DNA antigens from immune complexes deposited in the skin of patients with systemic lupus erythematosus.
    Zeng FQ; Yin RF; Tan GZ; Guo Q; Xu DQ
    Chin Med J (Engl); 2004 Jul; 117(7):1066-71. PubMed ID: 15265384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic lupus erythematosus (SLE). I. New insights into serology and pathogenesis].
    Feltkamp TE
    Ned Tijdschr Geneeskd; 1974 Feb; 118(5):166-70. PubMed ID: 4596539
    [No Abstract]   [Full Text] [Related]  

  • 27. Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.
    Okudaira K; Tanimoto K; Aikawa T; Horiuchi Y; Aotsuka S
    Scand J Rheumatol; 1983; 12(1):21-8. PubMed ID: 6601298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxyribonucleic acid and its antibodies in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1981 Dec; 22(6):323-31. PubMed ID: 7038879
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunopathological study on lupus nephritis (author's transl)].
    Kurata N; Hara I
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):260-7. PubMed ID: 314545
    [No Abstract]   [Full Text] [Related]  

  • 30. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
    Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
    Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating DNA-containing immune complexes in SLE.
    Steinman CR
    J Immunol; 1983 Apr; 130(4):1990-1. PubMed ID: 6833757
    [No Abstract]   [Full Text] [Related]  

  • 33. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
    Goto M; Tanimoto K; Horiuchi Y
    Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-DNA antibody, anti-idiotypic antibody and systemic lupus erythematosus].
    Sasaki T
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1159-63. PubMed ID: 2258660
    [No Abstract]   [Full Text] [Related]  

  • 35. [Juvenile dermatomyositis. Immunologic and clinical overlapping with systemic lupus erythematosus].
    Wollina U; Roth H; Grübner I
    Dermatol Monatsschr; 1985; 171(10):634-40. PubMed ID: 3877649
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detection of DNA anti-DNA immune complexes in systemic lupus erythematosus sera (author's transl)].
    Sarai T; Sakamoto K; Miyawaki S; Ofuji T
    Ryumachi; 1982 Feb; 22(1):20-7. PubMed ID: 7089743
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus.
    Tron F; Jacob L; Bach JF
    Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347
    [No Abstract]   [Full Text] [Related]  

  • 39. [Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo].
    Meffert H; Sönnichsen N; Metz D; Diezel W
    Dermatol Monatsschr; 1983 Feb; 169(2):92-6. PubMed ID: 6601590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.